Tag Archives: biomarker

FDA Approves Zejula (niraparib) as the Only Once-Daily PARP Inhibitor in First-Line Monotherapy Maintenance Treatment for Women with Platinum-Responsive Advanced Ovarian Cancer Regardless of Biomarker Status

Print this page London UK — 29 April 2020 — Dr. Hal Barron, Chief Scientific Officer and President R&D, GSK, said: “Women with advanced ovarian cancer have a five-year survival rate of less than 50%. This expanded indication means that many more women with this devastating disease can receive earlier treatment with Zejula, which can extend… Read More »

Biomarker predicts which patients with heart failure have a higher risk of dying within 1 to 3 years

Alana Prisco FINDINGS A UCLA-led study revealed a new way to predict which patients with “stable” heart failure — those who have heart injury but do not require hospitalization — have a higher risk of dying within one to three years.  Although people with stable heart failure have similar characteristics, some have rapid disease progression… Read More »

Bile duct biomarker? Protein found to pinpoint patients with a lethal cancer

Researchers at Tokyo Medical and Dental University (TMDU) unravel how a gene-repressing protein can predict survival outcomes in patients with a malignant form of bile duct cancer Tokyo, Japan – Biliary tract cancer is a type of cancer that occurs in the bile ducts, which transport bile from the liver to the duodenum. While generally rare,… Read More »